Literature DB >> 1539853

Electrophysiologic mechanisms responsible for inotropic responses to ketamine in guinea pig and rat myocardium.

M Endou1, Y Hattori, H Nakaya, Y Gotoh, M Kanno.   

Abstract

Inotropic and electrophysiologic effects of ketamine were investigated in cardiac preparations isolated from guinea pigs and rats. Ketamine produced a concentration-dependent negative inotropic effect in electrically driven guinea pig papillary muscles, an effect that was accompanied by a decrease in action potential duration at the 0-mV level (APD0). In contrast, ketamine produced a concentration-dependent positive inotropic effect in rat left atria in the presence of 10(-6) M propranolol. The increase in force of contraction was accompanied by an increase in APD0. Experiments using patch clamp techniques revealed that ketamine reduced the transsarcolemmal Ca2+ current (ICa) as well as the inward rectifier K+ current and delayed outward K+ current in guinea pig single ventricular cells. These results indicate that the shortening of APD0 observed in guinea pig papillary muscles might result from the suppression of ICa. In rat single ventricular cells ketamine reduced the Ca(2+)-insensitive transient outward current (Ito) and did not enhance ICa, suggesting that the ketamine-induced prolongation of APD0 observed in rat left atria is due to a decrease in Ito rather than an increase in ICa. Treatment of rat left atria with the specific Ca(2+)-insensitive Ito inhibitor 4-aminopyridine (2 mM) produced a positive inotropic effect and prolongation of APD0, and these effects were equivalent to those caused by the highest concentration of ketamine. In the presence of 4-aminopyridine, ketamine failed to induce a positive inotropic effect and instead caused a negative inotropic one. In conclusion, the negative and positive inotropic effects of ketamine may result from the suppression of ICa and Ito, respectively. The inhibitory action on these membrane currents may at least in part explain the species and tissue differences in inotropic responses to ketamine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539853

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  L-Carnitine rescues ketamine-induced attenuated heart rate and MAPK (ERK) activity in zebrafish embryos.

Authors:  Jyotshnabala Kanungo; Elvis Cuevas; Syed F Ali; Merle G Paule
Journal:  Reprod Toxicol       Date:  2011-10-20       Impact factor: 3.143

2.  Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel.

Authors:  B London; A Jeron; J Zhou; P Buckett; X Han; G F Mitchell; G Koren
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Acetyl L-carnitine targets adenosine triphosphate synthase in protecting zebrafish embryos from toxicities induced by verapamil and ketamine: An in vivo assessment.

Authors:  Xiaoqing Guo; Melanie Dumas; Bonnie L Robinson; Syed F Ali; Merle G Paule; Qiang Gu; Jyotshna Kanungo
Journal:  J Appl Toxicol       Date:  2016-05-18       Impact factor: 3.446

4.  Ketamine attenuates the Na+-dependent Ca2+ overload in rabbit ventricular myocytes in vitro by inhibiting late Na+ and L-type Ca2+ currents.

Authors:  An-tao Luo; Zhen-zhen Cao; Yu Xiang; Shuo Zhang; Chun-ping Qian; Chen Fu; Pei-hua Zhang; Ji-hua Ma
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150

5.  Effects of different dosages esketamine on cardiac conduction and heterogeneity of Cx43: the epicardial mapping in guinea pigs.

Authors:  Ying Cao; Yingnan Song; Zijun Wang; Jian Tang; Jing Yi; Yanqiu Liu; Li An; Zhijun Pan; Hong Gao
Journal:  Ann Transl Med       Date:  2022-07

6.  Human histamine H2 receptors can initiate cardiac arrhythmias in a transgenic mouse.

Authors:  U Gergs; J Weisgut; K Griethe; N Mißlinger; U Kirchhefer; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-24       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.